Table 6.

Sensitivity analysis

EffectReferenceOR (95% CI)P value
Full model 
Anatomic venous abnormality, yes No 2.9 (1.27-6.50) .011 
IBD, yes No 2.84 (0.95-8.47) .061 
IF, yes No 1.79 (0.60-5.38) .300 
CVC, yes No 1.5 (0.80-2.75) .217 
Congenital thrombophilia, no Yes 1.6 (0.65-4.00) .307 
Hospital at the time of first thrombosis, in Out 1.7 (0.86-3.31) .126 
Reduced model 
CVC, yes No 2.0 (1.14-3.51) .015 
Anatomic venous abnormality, yes No 2.3 (1.09-5.02) .029 
IBD, yes No 2.64 (0.90-7.76) .077 
EffectReferenceOR (95% CI)P value
Full model 
Anatomic venous abnormality, yes No 2.9 (1.27-6.50) .011 
IBD, yes No 2.84 (0.95-8.47) .061 
IF, yes No 1.79 (0.60-5.38) .300 
CVC, yes No 1.5 (0.80-2.75) .217 
Congenital thrombophilia, no Yes 1.6 (0.65-4.00) .307 
Hospital at the time of first thrombosis, in Out 1.7 (0.86-3.31) .126 
Reduced model 
CVC, yes No 2.0 (1.14-3.51) .015 
Anatomic venous abnormality, yes No 2.3 (1.09-5.02) .029 
IBD, yes No 2.64 (0.90-7.76) .077 

Results from logistic regression analyses, modeling odds of a repeat VTE; now only for those patients whose first VTE occurred on or after 1 January 2015 (n = 584). Initial predictors (full model) were included based on univariate results. Final model includes only significant predictors after using backward elimination.

CI, confidence interval; OR, odds ratio.

or Create an Account

Close Modal
Close Modal